Published in Neurology on June 28, 2005
Ten steps to identify atypical parkinsonism. J Neurol Neurosurg Psychiatry (2006) 1.04
Force control deficits in individuals with Parkinson's disease, multiple systems atrophy, and progressive supranuclear palsy. PLoS One (2013) 0.89
Are frontal cognitive and atrophy patterns different in PSP and bvFTD? A comparative neuropsychological and VBM study. PLoS One (2013) 0.82
Diagnostic accuracy of the clapping test in Parkinsonian disorders. J Neurol (2007) 0.80
Differentiation of atypical Parkinson syndromes. J Neural Transm (Vienna) (2017) 0.79
Localisation of the applause sign in a patient with acute bilateral lenticular infarction. J Neurol (2011) 0.77
Clinical Approach to Progressive Supranuclear Palsy. J Mov Disord (2016) 0.77
Applause sign in Alzheimer's disease: relationships to cognitive profile and severity of illness. J Neurol (2012) 0.76
The applause sign in cortical and cortical-subcortical dementia. J Neurol (2012) 0.76
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
The FAB: a Frontal Assessment Battery at bedside. Neurology (2000) 8.93
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology (1994) 4.24
Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet (1999) 4.17
Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 3.41
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Cognitive deficits in Parkinson's disease. J Neurol (1997) 2.49
The mental representation of hand movements after parietal cortex damage. Science (1996) 2.28
The neural system that bridges reward and cognition in humans: an fMRI study. Proc Natl Acad Sci U S A (2002) 2.26
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology (2008) 2.16
Cognitive planning deficit in patients with cerebellar atrophy. Neurology (1992) 2.03
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology (2001) 1.95
Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J Neurol Neurosurg Psychiatry (1994) 1.85
Eye movements in parkinsonian syndromes. Ann Neurol (1994) 1.84
Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol (1994) 1.81
Visual word recognition in the left and right hemispheres: anatomical and functional correlates of peripheral alexias. Cereb Cortex (2003) 1.79
Human autonomy and the frontal lobes. Part I: Imitation and utilization behavior: a neuropsychological study of 75 patients. Ann Neurol (1986) 1.77
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. Clin Auton Res (1998) 1.71
Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry (2005) 1.60
Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry (1999) 1.57
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Causal role of prefrontal cortex in the threshold for access to consciousness. Brain (2009) 1.56
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol (2001) 1.52
Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia (2002) 1.51
Comparison of apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology (2001) 1.51
Yes/no reversals as neurobehavioral sequela: a disorder of language, praxis, or inhibitory control? Eur J Neurol (2003) 1.45
Delayed response tasks and prefrontal lesions in man--evidence for self generated patterns of behaviour with poor environmental modulation. Neuropsychologia (1993) 1.45
Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology (1999) 1.42
Caregiving in progressive supranuclear palsy. Neurology (1998) 1.42
The role of dorsolateral prefrontal cortex in the preparation of forthcoming actions: an fMRI study. Cereb Cortex (2001) 1.42
Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI. J Neurol Neurosurg Psychiatry (1995) 1.38
Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain (2002) 1.38
Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology (2009) 1.37
Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology (1986) 1.35
Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 1.31
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry (2005) 1.31
Congruent unilateral impairments for real and imagined hand movements. Neuroreport (1995) 1.30
A reappraisal of reliability and validity studies in stroke. Stroke (1996) 1.29
Consensus statement on the diagnosis of multiple system atrophy. J Auton Nerv Syst (1998) 1.25
Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry (1998) 1.25
Preserved adjustment but impaired awareness in a sensory-motor conflict following prefrontal lesions. J Cogn Neurosci (2001) 1.24
Mild cognitive impairment in Parkinson's disease. Minerva Med (2011) 1.19
Visualizing cortical activation during mental calculation with functional MRI. Neuroimage (1996) 1.17
Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol (1988) 1.17
Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain (2005) 1.16
Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.15
Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol (1990) 1.14
[Obsessional-type compulsive behavior caused by bilateral circumscribed pallidostriatal necrosis. Encephalopathy caused by a wasp sting]. Rev Neurol (Paris) (1981) 1.11
Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci (2001) 1.11
Age-induced cognitive disturbances in Parkinson's disease. Neurology (1990) 1.06
Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology (2000) 1.05
Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol (2001) 1.05
Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol (1987) 1.05
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry (1998) 1.04
Frontal lobe function in progressive supranuclear palsy. Arch Neurol (1990) 1.02
[Loss of psychic self-activation. Compulsive activity of obsessional type. Bilateral lenticular lesion (author's transl)]. Rev Neurol (Paris) (1982) 1.01
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain (1997) 0.98
Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology (2000) 0.97
Measuring quality of life in PSP: the PSP-QoL. Neurology (2006) 0.96
Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol (1987) 0.96
Effects of closed traumatic brain injury and genetic factors on the development of Alzheimer's disease. Eur J Neurol (2001) 0.96
Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology (1998) 0.96
Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J Neurochem (2000) 0.96
Selective impairments in managerial knowledge following pre-frontal cortex damage. Cortex (1995) 0.94
Distinct prefrontal activations in processing sequence at the sentence and script level: an fMRI study. Neuropsychologia (1999) 0.94
Progressive supranuclear palsy: a survey of the disease course. Neurology (1998) 0.94
Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord (1999) 0.94
Encoding of sequence and boundaries of scripts following prefrontal lesions. Cortex (1996) 0.93
A selective impairment of hand posture for object utilization in apraxia. Cortex (1995) 0.93
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. J Neurol Neurosurg Psychiatry (1987) 0.93
Importance of deficits in executive functions. Lancet (1999) 0.92
Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions. Neurology (1998) 0.91
Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord (1992) 0.90
Lateral visually-guided saccades in progressive supranuclear palsy. Brain (1989) 0.90
BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology (2005) 0.90
Specific cerebral networks for maintenance and response organization within working memory as evidenced by the 'double delay/double response' paradigm. Cereb Cortex (2004) 0.90
Planning and script analysis following prefrontal lobe lesions. Ann N Y Acad Sci (1995) 0.89
Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med (1992) 0.89
Is the HM story only a "remote memory"? Some facts about hippocampus and memory in humans. Behav Brain Res (2001) 0.89
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist. Clin Neuropharmacol (1998) 0.89
Forced collectionism after orbitofrontal damage. Neurology (2002) 0.88
Pharmacological therapy in progressive supranuclear palsy. Arch Neurol (1998) 0.88
[Visuo-constructive problems and methods of compensation. Results for 85 patients with brain lesions]. Neuropsychologia (1981) 0.87
An ecological approach to planning dysfunction: script execution. Cortex (2000) 0.87
Self-monitoring in schizophrenia revisited. Neuroreport (2001) 0.87
The prefrontal cortex and conscious monitoring of action: an experimental study. Neuropsychologia (2003) 0.86
Neuropsychological features of progressive supranuclear palsy. Brain Cogn (1995) 0.86
[Anatomoclinical study of a case of prosopagnosia]. Rev Neurol (Paris) (1972) 0.85
Testing the model of caudo-rostral organization of cognitive control in the human with frontal lesions. Neuroimage (2013) 0.85
Language disturbances in corticobasal degeneration. Neurology (2000) 0.85
Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra (2012) 0.85
Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation. Neuropsychologia (1996) 0.85